Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REACH DM - Remote Assessments and Genetic Determinants of Myotonic Dystrophy

NCT07505342 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT07505342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07505342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REACH DM - Remote Assessments and Genetic Determinants of Myotonic Dystrophy
Lead sponsor
University of Rochester
Phase
Observational
Overall status
Recruiting
Start date
May 10, 2022
Completion date
January 1, 2030
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dm1, myotonic dystrophy type 1 (dm1)